Stay updated on MDMA in Moderate Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the MDMA in Moderate Hepatic Impairment Clinical Trial page.

Latest updates to the MDMA in Moderate Hepatic Impairment Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedResilient Pharmaceuticals is now listed as the Sponsor/Responsible Party, replacing Lykos Therapeutics, indicating a shift in the organization accountable for the study records. This change affects who coordinates communications and regulatory submissions for the trial.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page now displays an updated UI/build revision number (v3.5.3 instead of v3.5.2), reflecting a platform/version change rather than a change to the trial record itself.SummaryDifference0.1%

- Check25 days agoChange DetectedThe history now shows a new revision v3.5.2, replacing the previous revision v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedThe Record History now shows Revision: v3.5.0 as an added entry, and Revision: v3.4.3 is removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history now includes a new entry for Revision v3.4.3 and removes the previous v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision (v3.4.2) was added to the record history, and older notices including the lapse in government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.6%

Stay in the know with updates to MDMA in Moderate Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MDMA in Moderate Hepatic Impairment Clinical Trial page.